Your browser doesn't support javascript.
loading
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC).
Chen, Inna M; Johansen, Julia S; Theile, Susann; Hjaltelin, Jessica X; Novitski, Sif I; Brunak, Søren; Hasselby, Jane P; Willemoe, Gro L; Lorentzen, Torben; Madsen, Kasper; Jensen, Benny V; Wilken, Eva E; Geertsen, Poul; Behrens, Claus; Nolsoe, Christian; Hermann, Kirstine L; Svane, Inge Marie; Nielsen, Dorte.
Affiliation
  • Chen IM; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Johansen JS; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Theile S; Department of Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Hjaltelin JX; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.
  • Novitski SI; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hasselby JP; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Willemoe GL; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Lorentzen T; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Madsen K; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Jensen BV; Department of Gastroenterology, Unit of Surgical Ultrasound, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Wilken EE; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Geertsen P; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Behrens C; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Nolsoe C; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Hermann KL; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Svane IM; Department of Gastroenterology, Unit of Surgical Ultrasound, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Nielsen D; Department of Radiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
J Clin Oncol ; 40(27): 3180-3189, 2022 09 20.
Article in En | MEDLINE | ID: mdl-35476508
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Radiosurgery Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Affiliation country: Denmark Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Radiosurgery Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Affiliation country: Denmark Country of publication: United States